SEVERE HYPERTRIGLYCERIDEMIA
Clinical trials for SEVERE HYPERTRIGLYCERIDEMIA explained in plain language.
Never miss a new study
Get alerted when new SEVERE HYPERTRIGLYCERIDEMIA trials appear
Sign up with your email to follow new studies for SEVERE HYPERTRIGLYCERIDEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot every 3 months could stop pancreatitis in people with Sky-High triglycerides
Disease control Recruiting nowThis phase 3 trial tests a drug called plozasiran in 288 adults with severe hypertriglyceridemia (very high blood fats) who have had at least two pancreatitis attacks. Participants receive either the drug or a placebo every three months. The main goal is to see if the drug can pr…
Matched conditions: SEVERE HYPERTRIGLYCERIDEMIA
Phase: PHASE3 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New shot aims to tame dangerous fat levels in blood
Disease control Recruiting nowThis phase 2 trial tests an injectable drug called ION775 in 72 adults with high or severely high triglycerides. The goal is to see if it safely lowers fasting triglyceride levels. Participants continue standard care while receiving the study drug.
Matched conditions: SEVERE HYPERTRIGLYCERIDEMIA
Phase: PHASE2 • Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New shot aims to tame dangerously high blood fats
Disease control Recruiting nowThis study tests an injectable drug called solbinsiran in 60 adults with severe hypertriglyceridemia (very high blood fats). Participants receive two shots of either the drug or a placebo. The goal is to see if solbinsiran safely lowers triglycerides and related fats better than …
Matched conditions: SEVERE HYPERTRIGLYCERIDEMIA
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC